Kera Capital Partners Inc. purchased a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,643 shares of the company's stock, valued at approximately $393,000.
Other large investors also recently modified their holdings of the company. Envestnet Asset Management Inc. boosted its position in Avantor by 1.7% during the 2nd quarter. Envestnet Asset Management Inc. now owns 1,097,671 shares of the company's stock worth $23,271,000 after buying an additional 18,672 shares during the period. Dimensional Fund Advisors LP raised its position in Avantor by 8.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,434,195 shares of the company's stock worth $94,018,000 after purchasing an additional 350,247 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its holdings in Avantor by 4.6% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 25,440 shares of the company's stock worth $539,000 after buying an additional 1,119 shares during the period. Seven Eight Capital LP bought a new position in shares of Avantor during the second quarter worth about $642,000. Finally, First Eagle Investment Management LLC lifted its stake in shares of Avantor by 16.4% in the second quarter. First Eagle Investment Management LLC now owns 18,482 shares of the company's stock worth $392,000 after acquiring an additional 2,600 shares during the period. 95.08% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
AVTR has been the topic of a number of recent analyst reports. Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research report on Monday, October 28th. UBS Group reiterated a "neutral" rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a report on Friday. Royal Bank of Canada reissued an "outperform" rating and issued a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Barclays dropped their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Friday, October 25th. Finally, Wells Fargo & Company lowered their price objective on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating for the company in a research note on Monday, October 28th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $27.38.
View Our Latest Report on AVTR
Avantor Stock Down 1.9 %
Shares of AVTR traded down $0.43 on Friday, reaching $22.14. The company's stock had a trading volume of 6,042,606 shares, compared to its average volume of 3,101,021. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00. The stock has a market capitalization of $15.07 billion, a PE ratio of 48.13, a PEG ratio of 3.42 and a beta of 1.28. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The firm has a fifty day moving average of $21.45 and a 200-day moving average of $23.37.
Avantor Company Profile
(
Free Report)
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Read More
Before you consider Avantor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.
While Avantor currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.